Sharmila Dissanaike, M.D., FACS, FCCM
DirectoratHeron Therapeutics, Inc. /De/· In proxies 2023–2025
Sharmila Dissanaike, M.D., FACS, FCCM is Director of Heron Therapeutics, Inc. /De/.
Experience
- Heron Therapeutics, Inc. /De/Public company · 3 yr
- Director2023 – Present · 3 yrStock in role -87%
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?